Daniela Van Eickels
- Prescribed doses and effect on asthma treatment outcomes of extrafine (ciclesonide) vs standard particle inhaled corticosteroids (ICS)By David Price, Daniela Van Eickels, Matthias Binek, Mona Khalid, Ron M.C. Herings, Jetty Overbeek, Richard Dekhuijzen, Thys Van der Molen, Wim Van Aalderen, Gene Colice, Theresa Guilbert, Eliot Israel, Richard Martin, Dirkje Postma, Nicolas Roche, Vicky Thomas and Cristiana MiglioDavid Price1Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom2Research in Real Life, RiRL, Singapore, Singapore15Small Airways Study Group, Respiratory Effectiveness Group, Cambridge, United KingdomDaniela Van Eickels3Emerging Markets Medical Affairs, Takeda Pharmaceuticals International GmbH, Zurich, SwitzerlandMatthias Binek3Emerging Markets Medical Affairs, Takeda Pharmaceuticals International GmbH, Zurich, SwitzerlandMona Khalid4Epidemiology, Takeda Development Centre Europe Ltd, London, United KingdomRon M.C. Herings5PHARMO Institute for Drug Outcomes Research, PHARMO Institute, Utrecht, NetherlandsJetty Overbeek5PHARMO Institute for Drug Outcomes Research, PHARMO Institute, Utrecht, NetherlandsRichard Dekhuijzen6Radboud University, Nijmegen Medical Centre, Nijmegen, NetherlandsThys Van der Molen7University of Groningen, University Medical Center Groningen, Groningen, NetherlandsWim Van Aalderen8Emma's Children Hospital, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands15Small Airways Study Group, Respiratory Effectiveness Group, Cambridge, United KingdomGene Colice9School of Medicine, Washington Hospital Center and George Washington University, Washington, DC United States15Small Airways Study Group, Respiratory Effectiveness Group, Cambridge, United KingdomTheresa Guilbert10Cincinnati Children's Hospital Medical Center, Cincinnati Children's Hospital, Cincinnati, OH United States15Small Airways Study Group, Respiratory Effectiveness Group, Cambridge, United KingdomEliot Israel11Brigham and Women's Hospital and Harvard Medical School, Boston, MA United States15Small Airways Study Group, Respiratory Effectiveness Group, Cambridge, United KingdomRichard Martin12Department of Medicine, National Jewish Health, Denver, CO United States15Small Airways Study Group, Respiratory Effectiveness Group, Cambridge, United KingdomDirkje Postma7University of Groningen, University Medical Center Groningen, Groningen, Netherlands15Small Airways Study Group, Respiratory Effectiveness Group, Cambridge, United KingdomNicolas Roche13Service de Pneumologie AP-HP, Hôpitaux Universitaires Paris Centre, Groupe Hospitalier Cochin, Paris, France15Small Airways Study Group, Respiratory Effectiveness Group, Cambridge, United KingdomVicky Thomas14Research in Real Life, RiRL, Cambridge, United KingdomCristiana Miglio14Research in Real Life, RiRL, Cambridge, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.